EQUASENS (EQS.PA) Stock Fundamental Analysis
EPA:EQS - Euronext Paris - Matif - FR0012882389 - Common Stock - Currency: EUR
Overall EQS gets a fundamental rating of 6 out of 10. We evaluated EQS against 12 industry peers in the Health Care Technology industry. EQS scores excellent points on both the profitability and health parts. This is a solid base for a good stock. EQS is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
EQS had positive earnings in the past year.
In the past year EQS had a positive cash flow from operations.
Each year in the past 5 years EQS has been profitable.
Each year in the past 5 years EQS had a positive operating cash flow.
1.2 Ratios
EQS has a better Return On Assets (10.45%) than 91.67% of its industry peers.
EQS has a Return On Equity of 19.87%. This is amongst the best in the industry. EQS outperforms 83.33% of its industry peers.
The Return On Invested Capital of EQS (14.93%) is better than 91.67% of its industry peers.
EQS had an Average Return On Invested Capital over the past 3 years of 17.88%. This is significantly above the industry average of 7.83%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.45% | ||
| ROE | 19.87% | ||
| ROIC | 14.93% |
ROA(3y)12.34%
ROA(5y)11.68%
ROE(3y)23.5%
ROE(5y)22.83%
ROIC(3y)17.88%
ROIC(5y)18.18%
1.3 Margins
The Profit Margin of EQS (19.64%) is better than 83.33% of its industry peers.
EQS's Profit Margin has improved in the last couple of years.
The Operating Margin of EQS (22.49%) is better than 91.67% of its industry peers.
EQS's Operating Margin has been stable in the last couple of years.
EQS has a Gross Margin (68.63%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of EQS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 22.49% | ||
| PM (TTM) | 19.64% | ||
| GM | 68.63% |
OM growth 3Y-2.18%
OM growth 5Y-0.84%
PM growth 3Y6.2%
PM growth 5Y4.59%
GM growth 3Y-0.43%
GM growth 5Y0.31%
2. Health
2.1 Basic Checks
EQS has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, EQS has more shares outstanding
EQS has more shares outstanding than it did 5 years ago.
EQS has a better debt/assets ratio than last year.
2.2 Solvency
EQS has an Altman-Z score of 3.50. This indicates that EQS is financially healthy and has little risk of bankruptcy at the moment.
EQS has a Altman-Z score of 3.50. This is in the better half of the industry: EQS outperforms 75.00% of its industry peers.
The Debt to FCF ratio of EQS is 1.67, which is an excellent value as it means it would take EQS, only 1.67 years of fcf income to pay off all of its debts.
EQS has a better Debt to FCF ratio (1.67) than 66.67% of its industry peers.
EQS has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.15, EQS is doing good in the industry, outperforming 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 1.67 | ||
| Altman-Z | 3.5 |
ROIC/WACC1.97
WACC7.59%
2.3 Liquidity
EQS has a Current Ratio of 1.09. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of EQS (1.09) is comparable to the rest of the industry.
EQS has a Quick Ratio of 1.00. This is a normal value and indicates that EQS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.00, EQS is in line with its industry, outperforming 41.67% of the companies in the same industry.
The current and quick ratio evaluation for EQS is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.09 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
EQS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.99%.
The Earnings Per Share has been growing by 13.04% on average over the past years. This is quite good.
The Revenue has decreased by -3.56% in the past year.
Measured over the past years, EQS shows a quite strong growth in Revenue. The Revenue has been growing by 8.16% on average per year.
EPS 1Y (TTM)-12.99%
EPS 3Y15.35%
EPS 5Y13.04%
EPS Q2Q%-21.89%
Revenue 1Y (TTM)-3.56%
Revenue growth 3Y8.56%
Revenue growth 5Y8.16%
Sales Q2Q%-4.1%
3.2 Future
The Earnings Per Share is expected to grow by 8.38% on average over the next years. This is quite good.
Based on estimates for the next years, EQS will show a small growth in Revenue. The Revenue will grow by 5.58% on average per year.
EPS Next Y-27.4%
EPS Next 2Y-2.7%
EPS Next 3Y8.38%
EPS Next 5YN/A
Revenue Next Year-5.14%
Revenue Next 2Y1.81%
Revenue Next 3Y5.84%
Revenue Next 5Y5.58%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
EQS is valuated correctly with a Price/Earnings ratio of 13.71.
EQS's Price/Earnings ratio is rather cheap when compared to the industry. EQS is cheaper than 91.67% of the companies in the same industry.
EQS is valuated cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 12.74, EQS is valued correctly.
83.33% of the companies in the same industry are more expensive than EQS, based on the Price/Forward Earnings ratio.
EQS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.10.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.71 | ||
| Fwd PE | 12.74 |
4.2 Price Multiples
66.67% of the companies in the same industry are more expensive than EQS, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, EQS is valued a bit cheaper than the industry average as 66.67% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.09 | ||
| EV/EBITDA | 8.4 |
4.3 Compensation for Growth
EQS has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.05
EPS Next 2Y-2.7%
EPS Next 3Y8.38%
5. Dividend
5.1 Amount
EQS has a Yearly Dividend Yield of 3.33%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.21, EQS pays a bit more dividend than its industry peers.
EQS's Dividend Yield is a higher than the S&P500 average which is at 2.33.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.33% |
5.2 History
The dividend of EQS is nicely growing with an annual growth rate of 8.96%!
Dividend Growth(5Y)8.96%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
44.47% of the earnings are spent on dividend by EQS. This is a bit on the high side, but may be sustainable.
The dividend of EQS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP44.47%
EPS Next 2Y-2.7%
EPS Next 3Y8.38%
EPA:EQS (3/7/2025, 7:00:00 PM)
38.1
+0.6 (+1.6%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners13.44%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap577.98M
Analysts83.33
Price Target71.04 (86.46%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.33% |
Yearly Dividend1.15
Dividend Growth(5Y)8.96%
DP44.47%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-14.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.57%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.71 | ||
| Fwd PE | 12.74 | ||
| P/S | 2.69 | ||
| P/FCF | 19.09 | ||
| P/OCF | 11.77 | ||
| P/B | 2.72 | ||
| P/tB | 8.5 | ||
| EV/EBITDA | 8.4 |
EPS(TTM)2.78
EY7.3%
EPS(NY)2.99
Fwd EY7.85%
FCF(TTM)2
FCFY5.24%
OCF(TTM)3.24
OCFY8.5%
SpS14.18
BVpS14.02
TBVpS4.48
PEG (NY)N/A
PEG (5Y)1.05
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.45% | ||
| ROE | 19.87% | ||
| ROCE | 17.39% | ||
| ROIC | 14.93% | ||
| ROICexc | 19.32% | ||
| ROICexgc | 59.06% | ||
| OM | 22.49% | ||
| PM (TTM) | 19.64% | ||
| GM | 68.63% | ||
| FCFM | 14.07% |
ROA(3y)12.34%
ROA(5y)11.68%
ROE(3y)23.5%
ROE(5y)22.83%
ROIC(3y)17.88%
ROIC(5y)18.18%
ROICexc(3y)23.8%
ROICexc(5y)24.68%
ROICexgc(3y)70.74%
ROICexgc(5y)71.14%
ROCE(3y)20.83%
ROCE(5y)21.18%
ROICexcg growth 3Y-16.59%
ROICexcg growth 5Y-12.82%
ROICexc growth 3Y-7.85%
ROICexc growth 5Y-8.24%
OM growth 3Y-2.18%
OM growth 5Y-0.84%
PM growth 3Y6.2%
PM growth 5Y4.59%
GM growth 3Y-0.43%
GM growth 5Y0.31%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 1.67 | ||
| Debt/EBITDA | 0.51 | ||
| Cap/Depr | 130.21% | ||
| Cap/Sales | 8.76% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 78.14% | ||
| Profit Quality | 71.64% | ||
| Current Ratio | 1.09 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 3.5 |
F-Score5
WACC7.59%
ROIC/WACC1.97
Cap/Depr(3y)98.83%
Cap/Depr(5y)145.04%
Cap/Sales(3y)6.18%
Cap/Sales(5y)8.15%
Profit Quality(3y)93.06%
Profit Quality(5y)90.44%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.99%
EPS 3Y15.35%
EPS 5Y13.04%
EPS Q2Q%-21.89%
EPS Next Y-27.4%
EPS Next 2Y-2.7%
EPS Next 3Y8.38%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.56%
Revenue growth 3Y8.56%
Revenue growth 5Y8.16%
Sales Q2Q%-4.1%
Revenue Next Year-5.14%
Revenue Next 2Y1.81%
Revenue Next 3Y5.84%
Revenue Next 5Y5.58%
EBIT growth 1Y-15.41%
EBIT growth 3Y6.19%
EBIT growth 5Y7.25%
EBIT Next Year-4.45%
EBIT Next 3Y14.95%
EBIT Next 5YN/A
FCF growth 1Y-27.84%
FCF growth 3Y12.59%
FCF growth 5Y17.34%
OCF growth 1Y-3.3%
OCF growth 3Y6.93%
OCF growth 5Y14.97%